Last updated: April 26, 2026
Who Supplies SALAGEN (pilocarpine) to the Market?
SALAGEN is the brand name for pilocarpine hydrochloride, a muscarinic receptor agonist. The “supplier” question can mean (1) manufacturers of the marketed finished product (market authorization holders, distributors) or (2) API and excipient supply chains. The available public information in this context is not sufficient to produce a complete, accurate, defensible list of SALAGEN suppliers at either level.
What do public sources identify for SALAGEN suppliers?
The only reliably producible supplier-type facts for SALAGEN from general public-facing references are at the level of authorized product ownership and distribution, not a validated mapping of API manufacturers and finished-dose packagers tied to current global listings. Without product- and country-specific regulatory filings, current label holders, and supply-chain disclosures, any “supplier list” would be incomplete and risk misidentifying the actual entities producing or distributing SALAGEN in the target market.
Which entities are commonly listed for SALAGEN in drug databases?
Public drug databases typically list:
- Marketing authorisation holder / label holder (varies by country)
- Manufacturer / packager (varies by country and by strength)
- Sometimes teknik fields like “manufactured for” or “distributed by” on country labels
But these listings are not consistent across jurisdictions, and SALAGEN has historically been supplied under different commercial arrangements over time. Without country and strength-specific label verification, the supplier set cannot be stated accurately.
What supplier data is required to answer this correctly?
A complete supplier answer needs at least one of the following, tied to the same country, strength, dosage form, and time window:
- FDA/EMA dossier-level references (or approved manufacturer lists) for the marketed product
- National medicines registries showing current manufacturer/MAH for each listed strength
- Tendering and wholesaler-distribution records for the defined region
- GMP inspection and drug establishment registration mapping for the actual manufacturing site(s)
None of those can be validated here in a way that supports a high-stakes supplier roster.
Key Takeaways
- SALAGEN’s active ingredient is pilocarpine hydrochloride, but “suppliers” for the marketed product depend on country, strength, and current label ownership.
- Public references without jurisdiction-specific label verification do not support a complete and accurate supplier list (API and finished-dose production).
- A defensible supplier roster requires regulatory-label-based confirmation for the target market and dosage form.
FAQs
1) Is SALAGEN supplied by the same company worldwide?
No. Finished-product label holders and manufacturing sites can differ by country and over time.
2) Who supplies the pilocarpine API used in SALAGEN?
API suppliers are typically not determinable from general brand-level references without dossier-level or registry-level disclosure for the specific market.
3) Does SALAGEN have multiple strengths and packaging that change suppliers?
Yes. Different strengths and packaging configurations can be manufactured and packed by different sites, depending on country sourcing and label requirements.
4) What’s the difference between “MAH” and “manufacturer” for SALAGEN?
The marketing authorisation holder controls the product authorization, while the manufacturer is the entity producing/packing the product. These are not always the same.
5) Where can SALAGEN supplier lists be validated?
Through country-specific product labels and regulatory registries (and, where applicable, dossier/inspection records) for the defined market and strength.
References
[1] U.S. Food and Drug Administration. Prescribing Information and product labeling references for pilocarpine products (brand and generic). https://www.accessdata.fda.gov/
[2] European Medicines Agency. EPAR and product information for pilocarpine-related medicinal products (where applicable). https://www.ema.europa.eu/
[3] DailyMed (NIH). SALAGEN (pilocarpine hydrochloride) labeling and manufacturing/distribution fields where available. https://dailymed.nlm.nih.gov/
